U.S. Assisted Reproductive Technology Market Is Projected To Grow Robustly By 2030

U.S. Assisted Reproductive Technology Market Summary

The U.S. assisted reproductive technology market size was valued at USD 5.76 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 5.1% from 2024 to 2030. One of the primary factors driving market growth is the natural decline in fertility associated with increasing maternal age, which also raises the likelihood of chromosomal abnormalities and other fertility-related health conditions. Moreover, the rising incidence of infertility, along with advancements in medical technology and improving success rates of procedures like in-vitro fertilization (IVF) and artificial insemination, is expected to significantly propel the market forward during the forecast period.

The fertility rate in the United States has been on a steady decline over the years. According to data published by the Centers for Disease Control and Prevention (CDC), the national birth rate fell substantially between 2007 and 2022, decreasing from 14.3 births per 1,000 individuals to 11.1 births. Several factors have contributed to this trend, including societal shifts such as delayed family planning, career prioritization, and broader lifestyle changes. These demographic and behavioral changes have increased the reliance on assisted reproductive technologies for conception.

Key Market Trends & Insights

• Among the various procedures available, the in-vitro fertilization (IVF) segment captured the highest revenue share in 2023, accounting for 91.7% of the overall market. IVF is increasingly preferred over other fertility treatments due to its comparatively higher success rates. It has emerged as the leading and most widely utilized method of assisted reproduction, addressing a range of infertility issues and offering improved chances of conception for both couples and individuals experiencing reproductive difficulties.
• The fertility clinics and other healthcare facilities end-use segment led the market in 2023, contributing to 80% of the total revenue. This segment is expected to grow at the fastest pace during the forecast period while maintaining its leading position. Fertility clinics serve as the primary point of care for patients seeking assisted reproductive treatment. These specialized facilities are equipped with advanced technologies and staffed with fertility experts, making them the preferred choice for both physicians and patients, especially in cases involving complex or advanced reproductive challenges.
• Fertility clinics remain the go-to option for diagnosing and treating a wide range of reproductive health issues due to their comprehensive services, skilled personnel, and the ability to manage personalized treatment plans. Their integral role in delivering effective and customized fertility solutions positions them as key contributors to the ongoing growth and evolution of the U.S. assisted reproductive technology market.

Order a free sample PDF**** of the**** U.S. Assisted Reproductive Technology Market**** Intelligence Study, published by Grand View Research.

Market Size & Forecast

• 2023 Market Size: USD 5.76 billion
• 2030 Projected Market Size: USD 8.08 billion
• CAGR (2024 - 2030): 5.1%

Key Companies & Market Share Insights

Companies are contributing to the market growth through the implementation of diverse strategies, including introducing new products, investing in R&D, and expanding their product portfolios. For instance, in January 2021, CooperSurgical acquired Embryo Options, a prominent player in cryo-storage software solutions for fertility clinics. Embryo Options platform was intended to aid the patients by giving access to its online resources to provide knowledge about stored specimens for future ART treatment cycles.

Key Players

• Cosmos Biomedical Ltd.
• Microm U.K. Ltd.
• CooperSurgical Inc.
• FUJIFILM Irvine Scientific
• Cryolab Ltd.
• Vitrolife AB
• European Sperm Bank
• Bloom IVF Centre
• Merck KGaA
• Ferring B.V.

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The U.S. assisted reproductive technology market continues to experience robust growth, driven by declining fertility rates, delayed parenthood, and rising infertility cases. Increasing success rates of IVF and advanced treatment methods are encouraging wider adoption of assisted reproduction services. Fertility clinics dominate the market, offering specialized care and tailored solutions that address diverse reproductive challenges. As more individuals seek alternative paths to parenthood, the demand for technologically advanced, accessible, and effective fertility treatments will continue to rise. With continued innovation, patient awareness, and clinical expertise, the U.S. market is poised to support and transform reproductive care for a growing population.